Author Correction: Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response

Nat Commun. 2020 Apr 16;11(1):1929. doi: 10.1038/s41467-020-15945-y.

Besma Benredjem^#^{1

2}, Jonathan Gallion^#³, Dennis Pelletier⁴, Paul Dallaire^{1

2}, Johanie Charbonneau², Darren Cawkill^{4

5}, Karim Nagi⁶, Mark Gosink⁴, Viktoryia Lukasheva⁷, Stephen Jenkinson^{4

8}, Yong Ren^{4

9}, Christopher Somps⁴, Brigitte Murat⁷, Emma Van Der Westhuizen^{7

10}, Christian Le Gouill⁷, Olivier Lichtarge³, Anne Schmidt⁴, Michel Bouvier¹¹, Graciela Pineyro^{12

13}

¹ Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
² CHU Sainte-Justine Research Center, Montréal, QC, H3T 1C5, Canada.
³ Baylor College of Medicine, Houston, TX, 77030, USA.
⁴ Pfizer Inc, Groton, CT, 06340, USA.
⁵ Apollo Therapeutics LLP, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX, UK.
⁶ College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.
⁷ Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
⁸ Pfizer Inc, La Jolla, CA, 92121, USA.
⁹ Decibel Therapeutics, 1325 Boylston Street, Boston, MA, 02215, USA.
¹⁰ Monash Institute of Pharmaceutical Sciences, Parkville, VIC, 3052, Australia.
¹¹ Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada. michel.bouvier@umontreal.ca.
¹² Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada. graciela.pineyro.filpo@umontreal.ca.
¹³ CHU Sainte-Justine Research Center, Montréal, QC, H3T 1C5, Canada. graciela.pineyro.filpo@umontreal.ca.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.